Adrian-Radu Vidra

Young Oncologists Committee member

Address Oncology Institute Prof. Dr. Ion Chiricuță
Cluj-Napoca
Country

Romania

vidra-radu

ESMO: Tell us a bit about your education and specialisation so far in your career

I graduated from University of Medicine "Iuliu Hatieganu" from Cluj-Napoca in 2002 and I am licensed in Greek-Catholic Theology at Babes-Bolyai University from Cluj-Napoca 2011.I worked for a period of time in the pharmaceutical industry and since 2012 I am resident physician in medical oncology at the Oncology Institute "Ion Chiricuta" from Cluj Napoca. In this year 2016, I am preparing for the specialisation final exam.

What is your current activity?

I am specialising in medical oncology, I work in the Day Care Hospital Unit at the Oncology Institute from Cluj Napoca and I am especially interested in breast cancer.

Why did you choose to become a medical oncologist?

Many reasons have made me choose this specialisation:

  • I am by nature-oriented to people and their sufferings
  • Medical oncology is one of the most dynamic medical field
  • The inter-dependence of many medical areas
  • I like the complexity of the cancer disease

What does your involvement with ESMO and the Young Oncologists Committee (YOC) mean to you?

For any young oncologist, ESMO as well as YOC provides an opportunity for personal development, offering research and educational opportunities. YOC is a place where any young oncologist will find support and collaboration through shared experience and international links. As part of YOC I think I can help others and myself constructing together a strong community. It is a joy and a unique opportunity to be part of this committee.

Do you have some good advice you would like to share with your international colleagues?

For a full and complete professional development, I think we need international exchanges, a good professional guidance/couching/mentoring and a special focus on  pathology of interest. I also believe that ESMO is the ideal platform for this purpose.